Table 1. Patient Characteristics Patient... | American Society of Hematology

Table 1.

Patient Characteristics

Patient No.	Age/Sex	Disease Duration (mo)	Performance Index (Karnofsky)	Stage at Time of 2-CdA	No. of Prior Systemic Treatments	No. of 2-CdA Cycles	Follow-up Post 2-CdA (mo)
1	41/M	52	80	IVA	6	5	1^*
2	73/M	66	70	IVB^†	6	4	3^*
3	60/F	90	90	IVA^†	0	5	36
4	72/F	55	70	IVA	5	2	20

Patient No.	Age/Sex	Disease Duration (mo)	Performance Index (Karnofsky)	Stage at Time of 2-CdA	No. of Prior Systemic Treatments	No. of 2-CdA Cycles	Follow-up Post 2-CdA (mo)
1	41/M	52	80	IVA	6	5	1^*
2	73/M	66	70	IVB^†	6	4	3^*
3	60/F	90	90	IVA^†	0	5	36
4	72/F	55	70	IVA	5	2	20

Death.

Large-cell variant of SS.